Health & Wellness

Tag: Public Health Economics

Colorful cartoon illustration showing a wine glass balanced against healthy organs, doctors, and prevention shields on a giant scale.

🍷 The 62-Disease Default Matrix: What Harvard's 2026 Alcohol Study Means for the Rest of Us

For decades, alcohol occupied one of the most confusing corners of public health. A major Harvard-linked review is now challenging many long-held assumptions, connecting alcohol to 62 diseases and suggesting there may be no safe threshold for cancer risk. The good news? The body is remarkably resilient, and many health improvements can begin soon after reducing alcohol consumption.

Read entire article

Tags: alcohol and cancer, alcohol health risks, alcohol prevention, alcohol research, alcohol use disorder, Alcoholic Cardiomyopathy, alcoholism, cancer prevention, CarpeDiem, Delirium Tremens Risk, dementia prevention, DSM-5 Criteria, Frédéric Marsanne, FUNanc1al, Harvard alcohol study, Harvard Alcohol Study 2026, health and wellness, healthy aging, healthy drinking, Liver Cirrhosis, liver health, longevity, Mendelian Randomization, public health, Public Health Economics, wellness
Illustration showing doctors and families celebrating as a giant shield labeled HPV Vaccine protects women and girls from virus characters, symbolizing hope, prevention, and the future eradication of cervical cancer.

🩺 Cervical Cancer Prevention: Lancet Confirms HPV Vaccine Drastically Cuts Mortality Risk

Sometimes progress arrives quietly. A landmark Lancet study reported zero cervical cancer deaths among vaccinated women aged 20–24 in England. One vaccine, a few seconds, and potentially thousands of lives saved.

Read entire article

Tags: At-Home HPV Test, Cancer Prevention, CarpeDiem, Cervical Cancer, Cervical Cancer Prevention, Disease Eradication, FUNanc1al, FunHealth, Health and Wellness, Healthcare Liabilities, HPV, HPV Self Testing, HPV Vaccine, Lancet, Lancet Medical Study, Longevity, Medicine, Metastatic Oncology, Pap Test, Public Health, Public Health Economics, Screening, Vaccines, WHO, Women's Health